These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15635619)

  • 21. Critical management in patients with severe enterovirus 71 infection.
    Wang JN; Yao CT; Yeh CN; Huang CC; Wang SM; Liu CC; Wu JM
    Pediatr Int; 2006 Jun; 48(3):250-6. PubMed ID: 16732789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features and treatment of serious brainstem encephalitis caused by enterovirus 71 infection].
    Liu XJ; Li W; Zhang YQ; Liu YM; Liu LZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):967-9. PubMed ID: 20113599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulized phosphodiesterase III inhibitor during warm ischemia attenuates pulmonary ischemia-reperfusion injury.
    Zhang J; Chen F; Zhao X; Aoyama A; Okamoto T; Fujinaga T; Shoji T; Sakai H; Cui Y; Bando T; Date H
    J Heart Lung Transplant; 2009 Jan; 28(1):79-84. PubMed ID: 19134535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
    Jeon Y; Ryu JH; Lim YJ; Kim CS; Bahk JH; Yoon SZ; Choi JY
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):952-6. PubMed ID: 16675238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy.
    Bhat G
    ASAIO J; 2006; 52(6):677-81. PubMed ID: 17117058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Milrinone in Enterovirus 71 Brain Stem Encephalitis.
    Wang SM
    Front Pharmacol; 2016; 7():82. PubMed ID: 27065870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deaths in children during an outbreak of hand, foot and mouth disease in Peninsular Malaysia--clinical and pathological characteristics.
    Shekhar K; Lye MS; Norlijah O; Ong F; Looi LM; Khuzaiah R; Marzuki I; Hussein I; Wong SL; Mohan J; Sinniah M; Abu Bakar S
    Med J Malaysia; 2005 Aug; 60(3):297-304. PubMed ID: 16379183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management.
    Lin TY; Chang LY; Hsia SH; Huang YC; Chiu CH; Hsueh C; Shih SR; Liu CC; Wu MH
    Clin Infect Dis; 2002 May; 34 Suppl 2():S52-7. PubMed ID: 11938497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
    Al-Shawaf E; Ayed A; Vislocky I; Radomir B; Dehrab N; Tarazi R
    J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):353-7. PubMed ID: 16750735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of milrinone on hemodynamics in an experimental septic shock model.
    Liet JM; Jacqueline C; Orsonneau JL; Gras-Leguen C; Potel G; Rozé JC
    Pediatr Crit Care Med; 2005 Mar; 6(2):195-9. PubMed ID: 15730608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Milrinone: some (medicolegal) thoughts beyond contractility, lusitropy, and cardiac output.
    Meyer S
    Crit Care Med; 2013 Nov; 41(11):e390-1. PubMed ID: 24162695
    [No Abstract]   [Full Text] [Related]  

  • 34. Milrinone improves lung compliance in patients receiving mechanical ventilation for cardiogenic pulmonary edema.
    Takeda S; Matsumura J; Ikezaki H; Kim C; Sato N; Nakanishi K; Sakamoto A; Ogawa R; Tanaka K
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):714-9. PubMed ID: 12803589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan.
    Kung CM; King CC; Lee CN; Huang LM; Lee PI; Kao CL
    J Med Virol; 2007 Jan; 79(1):60-8. PubMed ID: 17133556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation and pharmacological therapy in patients with cardiogenic pulmonary oedema.
    Fiutowski M; Waszyrowski T; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2004 Dec; 61(12):561-9; discussion 570. PubMed ID: 15815756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The authors reply.
    Chi CY; Wang SM; Liu CC
    Crit Care Med; 2013 Nov; 41(11):e391-2. PubMed ID: 24162696
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proper use of phosphodiesterase inhibitors according to the situations.
    Tanwiphongtrakun T; Inoue S; Furuya H
    Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):183-5. PubMed ID: 17037008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after pulmonary edema due to enterovirus 71 encephalitis.
    Nolan MA; Craig ME; Lahra MM; Rawlinson WD; Prager PC; Williams GD; Bye AM; Andrews PI
    Neurology; 2003 May; 60(10):1651-6. PubMed ID: 12771257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.